Genentech “Dear Doctor” Letter Suggests Herceptin Cardiotoxicity Risk Factors
This article was originally published in The Pink Sheet Daily
Executive Summary
Age and left ventricular function following chemotherapy may identify patients at greatest risk for cardiac dysfunction, the company says.